# Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical Application

> **NCT06335576** · — · NOT_YET_RECRUITING · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 89 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **OTHER:** This study is a single-arm and observational study with no intervention.

## Key facts

- **NCT ID:** NCT06335576
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-03-31
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 89 (ESTIMATED)
- **Last updated:** 2024-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06335576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06335576, "Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical Application". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06335576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*